84 results
Page 4 of 5
6-K
EX-99.1
yfbi6v
24 Mar 20
Sol-Gel Technologies Reports Full Year 2019 Financial Results and Corporate Update
4:38pm
6-K
EX-99.1
8xhjbk2ftfx
3 Mar 20
Current report (foreign)
8:03am
6-K
EX-1.1
j8vgi9 1vzru4lhhugs6
14 Feb 20
Sol-Gel Announces Pricing of Public Offering of Ordinary Shares and Warrants to Purchase
5:24pm
424B5
6qe8vpm38ivmuk4 tjke
13 Feb 20
Prospectus supplement for primary offering
9:57pm
6-K
EX-99.1
06a1am78n7vw
13 Feb 20
Sol-Gel Announces Positive Topline Results from Open-Label, Long-Term Safety
4:25pm
6-K
rx6lvnv0d8
13 Feb 20
Sol-Gel Announces Positive Topline Results from Open-Label, Long-Term Safety
4:25pm
6-K
EX-1.1
1e4dfdmv us5qy1
13 Jan 20
Current report (foreign)
12:00am
424B5
tbpzwgp0 m08laadtz
10 Jan 20
Prospectus supplement for primary offering
5:06pm
6-K
EX-99.1
iecxh02 sug5oidhlr
15 Nov 19
Sol-Gel Technologies Reports Third Quarter 2019 Financial Results and Corporate Update
9:02am
6-K
EX-99.1
s8vu tftp4i
13 Aug 19
Sol-Gel Technologies Reports Second Quarter 2019 Financial Results and Corporate Update
7:06am
6-K
EX-99.2
08kn9zw
13 Aug 19
Sol-Gel Technologies Reports Second Quarter 2019 Financial Results and Corporate Update
7:06am
6-K
EX-1.1
8upb2ht
8 Aug 19
Sol-Gel Announces Pricing of Public Offering of Ordinary Shares
4:03pm
6-K
EX-1.1
zbqs eifpaih
31 May 19
Open Market Sale Agreementsm
5:25pm
424B5
hy2gnl
31 May 19
Prospectus supplement for primary offering
5:23pm
6-K
EX-99.1
j5x v1zr40x1
22 May 19
Sol-Gel Technologies Reports First Quarter 2019 Financial Results and Corporate Update
7:58am
6-K
EX-99.1
ba2kf41
22 Mar 19
Current report (foreign)
8:00am
6-K
EX-99.1
8uji0jgxokstm jb
7 Jan 19
Current report (foreign)
6:32am
6-K
EX-99.1
bqgex7e
26 Dec 18
Sol-Gel Technologies Initiates Pivotal Phase III Clinical Program of TWIN for the Treatment of Acne Vulgaris
6:07am